首页> 外国专利> USE OF A VACCINE TARGETING A CRYPTIC TERT EPITOPE, FOR TREATING CANCER IN A HLA-A*0201-POSITIVE PATIENT HAVING A NON-IMMUNOGENIC TUMOR EXPRESSING TERT

USE OF A VACCINE TARGETING A CRYPTIC TERT EPITOPE, FOR TREATING CANCER IN A HLA-A*0201-POSITIVE PATIENT HAVING A NON-IMMUNOGENIC TUMOR EXPRESSING TERT

机译:使用疫苗靶向隐匿性睾丸瘤治疗具有非免疫原性表达表达的HLA-A * 0201阳性患者中的癌症

摘要

The invention pertains to the use of a tumor vaccine composed of two peptides of nine amino acids - the WT cryptic TERT572 (RLFFYRKSV, SEQ ID No: 1) expressed by tumor cells and its optimized variant TERT572Y (YLFFYRKSV, SEQ ID No: 2) - for treating cancer in a HLA-A*0201-positive patient having a non-immunogenic tumor expressing TERT.
机译:本发明涉及由两种九个氨基酸的肽组成的肿瘤疫苗的用途-肿瘤细胞表达的WT隐性TERT572(RLFFYRKSV,SEQ ID No:1)及其优化的变体TERT572Y(YLFFYRKSV,SEQ ID No:2) -用于在患有表达TERT的非免疫原性肿瘤的HLA-A * 0201阳性患者中治疗癌症。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号